James Wilson (scientist)

James M. Wilson is an American geneticist and medical researcher, known for his work on gene therapy, where he is regarded as one of the field's most prominent researchers.[1]

Biography

Wilson gained his BA in chemistry at Albion College in 1977, and his MD and PhD at the University of Michigan in 1984.[2] As of 2016, he works at the Penn Cardiovascular Institute of the University of Pennsylvania.[2][3] His research interests include genetic disorders of lipid metabolism, and gene therapy for dyslipidemias, coronary artery disease and congestive heart failure.[2]

In 1999, a patient in a clinical trial led by Wilson, Jesse Gelsinger, died after receiving a gene therapy treatment.[1][4]

References

  1. 1 2 Gene Therapy Emerges From Disgrace to Be the Next Big Thing, Again by Carl Zimmer August 13, 2013 Wired
  2. 1 2 3 James M. Wilson, University of Pennsylvania
  3. Gene therapy; an interview Scientific American
  4. James M. Wilson (2009), "A History Lesson for Stem Cells", Science 324: 727–728 via JSTOR, (registration required (help))
This article is issued from Wikipedia - version of the Monday, January 18, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.